Press Releases

AMA: Trump administration requiring pricing information in TV drug ads

| 2 Min Read

Statement attributable to:

Barbara L. McAneny, MD 

President, American Medical Association

“The Trump Administration has taken a step in the right direction by requiring pricing information in direct-to-consumer television advertising of prescription drugs. Last year, the AMA called for regulations requiring the ads to include the manufacturer’s list price of those drugs, and we have supported similar legislative efforts. This small dose of transparency will help patients have a more complete picture when faced with prescription drug ads. 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

John Whyte, MD, MPH, interview at MATTER

AMA CEO: AI is not medicine’s future—“this is happening now.”

| 6 Min Read
Health care professionals about to begin a telehealth appointment

Practice ownership linked to physicians’ use of telehealth

| 5 Min Read
Pharmacist filling prescription

Investigating pharmacists’ refusal to fill valid physician orders

| 6 Min Read
Moving Medicine-Sutton and Bacher

CMS launches modernized physician ACO model

| 6 Min Read